NOW AVAILABLE!
2022 19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
The 2022 19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations’ current and projected future capacity and production. In this year’s annual report, we provide case study summaries sponsored by Evaluating Biopharma, a virtual networking and educational event series. Each highlights a specific issue affecting the industry, an overview of the situation, discussion summary, and overall solution and conclusion.
ISBN 978-1-934106-43-3
Highlights
This report’s ~500 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with an in-depth analysis of capacity, production trends, benchmarks, and much more.
Coverage
- In-depth analysis of key data, capacity, production trends, and benchmarks
- Budget trends and impact of the current economic environment
- Downstream purification problems and issues
- Current and projected industry bottlenecks
- Capacity utilization and current production levels
- Capacity bottlenecks – what’s being done to resolve
- Production trends and Outsourcing trends
- International offshoring through 2027
- Range of titers, growth
- Disposables: Spending growth; downstream uses; L&E’s; reasons for increasing/ restricting; budget increases; vendor satisfaction
- Batch failure rates & trends
- Selecting a CMO — Problems & solutions
- Quality management & PAT implementation
- Hiring and employment growth
- Supplier growth rates, and much more
Compare 140+ Biomanufacturers vs CMOs; U.S. vs. European & Global Biomanufacturing
- Overview
- Methodology
- CHAPTER 0: Demographics
- CHAPTER 1: Introduction and Discussion
- CHAPTER 2: Overview of Critical Issues in Bioprocessing
- CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing
- CHAPTER 4: Capacity Utilization
- CHAPTER 5: Current and Future Capacity Constraints
- CHAPTER 6: Future Capacity Expansions
- CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing
- CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing
- CHAPTER 9: Downstream Purification
- CHAPTER 10: Hiring, Employment Growth and Training in Biopharmaceutical Manufacturing
- CHAPTER 11: New Methods: Continuous and Process Intensification, Cell and Gene Therapies [UPDATED!]
- CHAPTER 12: Suppliers to Biopharmaceutical Manufacturing and Life Sciences
Click here for the Table of Contents
- 140+ Biopharma companies surveyed
- 130+ industry vendors and direct suppliers of materials
- 25 Countries represented
- ~500 Pages
- 12 Chapters
- 200+ Graphs and 20+ Tables
- Subject Matter Experts providing analysis
- Independent Sponsoring Organizations
Click here for a free copy of our 2021 Top Trends in Biomanufacturing White Paper
SPECIAL! – Click here to listen to a recent podcast between Dodi Axelson, Discovery Matters Podcast and Eric Langer, Managing Partner of BioPlan Associates about BioPlan’s Annual Report on Biopharmaceutical Manufacturing Capacity and Production!
TESTIMONIALS for Annual Report
“If you really want to get under the skin of the industry, this [BioPlan report] is where you go…” – Dodi Axelson, Discovery Matters Podcast, Dec 2021
“Everything you need to know about the biopharma industry is in the BioPlan Annual Report…is the Granddaddy of reports…many pages if you want to get under the skin of the industry, this is where you go.” – Dodi Axelson, Discovery Matters Podcast, Dec 2021
“Your report has delivered significant value to us. We use it as a fundamental part of the research for our strategic planning. This report has helped us see market shifts, such as the predicted increase in needs for biotech-focused CMO’s that we used to position our company to better serve our clients. We consider this a must-have report to keep our business focused in the right direction.” – Jeff Hargroves, President, ProPharma Group
“BioPlan Associates Annual Reports are a valuable independent resource for monitoring drug manufacturing activities, trends and future needs.”- Jerold Martin, Former Pall Life Sciences
“The BioPlan Annual Report and Survey is and has always been a must-read, as it is the most comprehensive survey and results analysis to determine trends, requirements, and new demand of the biopharmaceutical industry. The report’s data and interpretation of the survey results are an invaluable tool for biomanufacturers and suppliers alike, as it thoroughly highlights the current status and future necessities. It not only is a snapshot report but a multi-year evaluation.” – Maik Jornitz, President, G-Con, LLC
“I have found each BioPlan Associates “Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production” to be particularly useful in my work. As managing editor for BioProcessing Journal, I refer to my print copies of the biomanufacturing survey reports regularly when recruiting and editing manuscripts. They are valuable components of my journal production ‘toolkit.'”- Marci J. Brown, Managing Editor, BioProcessing Journal
